Matthew was Chief Executive Officer and Chief Medical Officer for BioElectron Technology. Matthew Klein joined PTC Therapeutics in 2019. Matthew served as Global Head of Gene and Mitochondrial Therapies at PTC Therapeutics.
Matthew Klein is currently
Create your alert
to follow the career of Matthew Klein.
Matthew Klein has a Summa Cum Laude degree from University of Pennsylvania - The Wharton School and a Doctor of Medicine from Yale University - School of Medicine.
They have also studied at University of Pennsylvania - The Wharton School :
Find more alumni from University of Pennsylvania - The Wharton School
They have also studied at Yale University - School of Medicine :
Find more alumni from Yale University - School of Medicine
Do you need to know more about Matthew Klein? More results.
Report an error
Update the org chart details of Matthew Klein.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.